ARCHIVES

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

This article is from The Cancer Letter archive.

Vol. 07 No. 15 | April 10, 1981

Download PDF Visit The Full Archive

Related Articles

NCI’s Douglas Lowy and John Schiller Honored with National Medal

December 12, 2014

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

July 2, 2004

California approves $3 billion program for stem-cell research.

November 5, 2004

Michigan’s Zhang Wins “Protein Science Olympics”

January 14, 2011

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975

IM Recommends Pay Increase for Many At NIH, Other Steps; Adamson Objects To “Primrose Path Of Centralization

March 3, 1989